Brain activity linked to TNF inhibitor response in RA

February 12, 2013
Brain activity linked to TNF inhibitor response in RA
Patients with rheumatoid arthritis who respond to tumor necrosis factor inhibitors show changes in activity in pain-related areas of the brain before clinical signs of improvement are observed, according to a study published in the February issue of Arthritis & Rheumatism.

(HealthDay)—Patients with rheumatoid arthritis who respond to tumor necrosis factor inhibitors (TNFi) show changes in activity in pain-related areas of the brain before clinical signs of improvement are observed, according to a study published in the February issue of Arthritis & Rheumatism.

Juergen Rech, M.D., from the University of Erlangen-Nuremberg in Germany, and colleagues performed functional magnetic resonance imaging (MRI) of the and anatomic MRI of the hand in 10 patients with active rheumatoid before and up to 28 days after starting treatment with TNFi.

The researchers found that patients who responded to TNFi had a greater mean decrease in Disease Activity Score in 28 joints 28 days after starting treatment. Responders had greater activation of the thalamic, limbic, and associative areas of the brain, which decreased within three days of starting treatment. This was followed by clinical responses after seven days and responses on the hand MRI 28 days after starting treatment.

"These data suggest that response to TNFi depends on brain activity in patients, reflecting the subjective perception of disease," Rech and colleagues conclude.

One author disclosed receiving speaking fees from several pharmaceutical companies.

More information: Abstract
Full Text (subscription or payment may be required)

Related Stories

Bring the feet when diagnosing, treating rheumatoid arthritis

December 7, 2011

When diagnosing and treating patients with rheumatoid arthritis (RA), clinical research focuses primarily on the joints in the upper body. However, research carried out by rheumatologist Hetty Baan at the University of Twente ...

Data suggest smoking doesn't impact RA treatment response

December 21, 2012

(HealthDay)—For patients with early rheumatoid arthritis (RA), smoking status does not impact treatment response to early combination therapy or initial methotrexate treatment with step-up therapy, according to a study ...

Recommended for you

Team finds gene that confirms existence of psoriatic arthritis

February 5, 2015

PsA is a common form of inflammatory form of arthritis causing pain and stiffness in joints and tendons that can lead to joint damage. Nearly all patients with PsA also have skin psoriasis and, in many cases, the skin disease ...

Blocking one receptor could halt rheumatoid arthritis

September 10, 2014

Researchers at the University of Illinois at Chicago College of Medicine have shown for the first time how the activation of a receptor provokes the inflammation and bone degradation of rheumatoid arthritis—and that activation ...

Low back pain? Don't blame the weather

July 10, 2014

Australian researchers reveal that sudden, acute episodes of low back pain are not linked to weather conditions such as temperature, humidity, air pressure, wind direction and precipitation. Findings published in Arthritis ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.